CAM
PFE icon

Claret Asset Management’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.48M Buy
308,522
+15,729
+5% +$381K 0.97% 27
2025
Q1
$7.42M Sell
292,793
-3,099
-1% -$78.5K 1.07% 24
2024
Q4
$7.85M Buy
295,892
+175,273
+145% +$4.65M 1.24% 22
2024
Q3
$3.49M Sell
120,619
-889
-0.7% -$25.7K 0.57% 35
2024
Q2
$3.4M Sell
121,508
-1,745
-1% -$48.8K 0.6% 35
2024
Q1
$3.42M Buy
123,253
+29,353
+31% +$814K 0.57% 37
2023
Q4
$2.7M Buy
93,900
+85,911
+1,075% +$2.47M 0.48% 39
2023
Q3
$265K Buy
7,989
+524
+7% +$17.4K 0.05% 113
2023
Q2
$274K Buy
7,465
+187
+3% +$6.86K 0.05% 119
2023
Q1
$297K Buy
7,278
+50
+0.7% +$2.04K 0.06% 110
2022
Q4
$370K Buy
7,228
+209
+3% +$10.7K 0.08% 105
2022
Q3
$307K Buy
7,019
+550
+9% +$24.1K 0.07% 108
2022
Q2
$339K Sell
6,469
-73
-1% -$3.83K 0.07% 108
2022
Q1
$339K Buy
6,542
+329
+5% +$17K 0.07% 111
2021
Q4
$367K Sell
6,213
-205
-3% -$12.1K 0.07% 116
2021
Q3
$276K Sell
6,418
-3,637
-36% -$156K 0.05% 137
2021
Q2
$394K Buy
10,055
+35
+0.3% +$1.37K 0.06% 125
2021
Q1
$363K Sell
10,020
-748
-7% -$27.1K 0.07% 128
2020
Q4
$396K Sell
10,768
-42,646
-80% -$1.57M 0.08% 126
2020
Q3
$1.96M Sell
53,414
-500
-0.9% -$18.3K 0.44% 47
2020
Q2
$1.76M Buy
53,914
+3,845
+8% +$126K 0.42% 49
2020
Q1
$1.63M Buy
50,069
+10,330
+26% +$337K 0.46% 48
2019
Q4
$1.56M Sell
39,739
-701
-2% -$27.5K 0.3% 61
2019
Q3
$1.45M Sell
40,440
-136
-0.3% -$4.89K 0.3% 66
2019
Q2
$1.76M Sell
40,576
-93
-0.2% -$4.03K 0.36% 60
2019
Q1
$1.73M Sell
40,669
-425
-1% -$18K 0.34% 60
2018
Q4
$1.79M Sell
41,094
-1,012
-2% -$44.2K 0.4% 60
2018
Q3
$1.86M Buy
42,106
+1,296
+3% +$57.1K 0.36% 63
2018
Q2
$1.48M Sell
40,810
-1,016
-2% -$36.9K 0.3% 66
2018
Q1
$1.48M Sell
41,826
-14
-0% -$497 0.34% 63
2017
Q4
$1.52M Buy
+41,840
New +$1.52M 0.33% 64